120 related articles for article (PubMed ID: 2806759)
1. Histological evaluation of mast cells in rat gastric mucosal lesions induced by compound 48/80.
Arisawa T; Nakazawa S; Asai J; Tsukamoto Y
Digestion; 1989; 43(1-2):87-97. PubMed ID: 2806759
[TBL] [Abstract][Full Text] [Related]
2. Anti-gastric acid secretory mechanism of 1,6-dihydro-2-[2-(2-methylpropoxy)anilino]-6-oxo-5-pyrimidinecarboxylic acid. Effect on mucosal mast cell.
Ishizuka Y; Kamisaki T; Sato M
Arzneimittelforschung; 1996 Sep; 46(9):919-22. PubMed ID: 8876942
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of omeprazole against acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Kobayashi T; Ohta Y; Inui K; Yoshino J; Nakazawa S
Pharmacol Res; 2002 Jul; 46(1):75-84. PubMed ID: 12208124
[TBL] [Abstract][Full Text] [Related]
4. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Ishiguro I
Pharmacol Res; 1999 Apr; 39(4):261-7. PubMed ID: 10208755
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of DS-4574, a peptidoleukotriene antagonist with mast cell stabilizing action, on compound 48/80-induced gastric mucosal lesions in rats.
Tabuchi Y; Kawarabayashi K; Furuhama K
Agents Actions; 1994 Mar; 41(1-2):21-4. PubMed ID: 7521568
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of irritative activity of compound 48/80 on rat gastric mucosa.
Takeuchi K; Ohtsuki H; Nobuhara Y; Okabe S
Digestion; 1986; 33(1):34-44. PubMed ID: 3940236
[TBL] [Abstract][Full Text] [Related]
7. Effect of gefarnate on acute gastric mucosal lesion progression in rats treated with compound 48/80, a mast cell degranulator, in comparison with that of teprenone.
Ohta Y; Kobayashi T; Imai Y; Inui K; Yoshino J; Nakazawa S
Biol Pharm Bull; 2005 Aug; 28(8):1424-30. PubMed ID: 16079487
[TBL] [Abstract][Full Text] [Related]
8. The effect of compound 48/80 and of electrical field stimulation on mast cells in the isolated mouse stomach.
Stanovnik L; Logonder-Mlinsek M; Erjavec F
Agents Actions; 1988 Apr; 23(3-4):300-3. PubMed ID: 2456001
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of compound 48/80-induced gastric lesions in rats.
Takeuchi K; Ohtsuki H; Okabe S
Dig Dis Sci; 1986 Apr; 31(4):392-400. PubMed ID: 3956335
[TBL] [Abstract][Full Text] [Related]
10. Effect of cimetidine on the mucosal hydroxyproline content of rat gastric lesions induced by compound 48/80.
Arisawa T; Tsukamoto Y; Goto H; Hase S; Tsuchida T; Kuroiwa M; Suzuki T; Ohara A; Segawa K; Sugiyama S
Arzneimittelforschung; 1991 Oct; 41(10):1058-60. PubMed ID: 1799384
[TBL] [Abstract][Full Text] [Related]
11. Relationship between changes of active oxygen metabolism and blood flow and formation, progression, and recovery of lesions is gastric mucosa of rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Nishida K; Ishiguro I
Dig Dis Sci; 1997 Jun; 42(6):1221-32. PubMed ID: 9201088
[TBL] [Abstract][Full Text] [Related]
12. Plaunotol prevents the progression of acute gastric mucosal lesions induced by compound 48/80, a mast cell degranulator, in rats.
Ohta Y; Kamiya Y; Imai Y; Arisawa T; Nakano H
Pharmacology; 2005 Jul; 74(4):182-92. PubMed ID: 15855831
[TBL] [Abstract][Full Text] [Related]
13. Participation of xanthine-xanthine oxidase system and neutrophils in development of acute gastric mucosal lesions in rats with a single treatment of compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Ishiguro I
Dig Dis Sci; 1999 Sep; 44(9):1865-74. PubMed ID: 10505727
[TBL] [Abstract][Full Text] [Related]
14. Effect of cimetidine and omeprazole on aspirin- and taurocholate-induced gastric mucosal damage in the rat.
Utley RJ; Salim AS; Carter DC
Gut; 1985 Aug; 26(8):770-5. PubMed ID: 4018641
[TBL] [Abstract][Full Text] [Related]
15. Repeated recurrence of gastric mucosal lesions in rats after a single treatment with compound 48/80, a mast cell degranulator.
Ohta Y; Kobayashi T; Inui K; Yoshino J; Nakazawa S
J Physiol Pharmacol; 2009 Dec; 60 Suppl 7():139-48. PubMed ID: 20388957
[TBL] [Abstract][Full Text] [Related]
16. Effects of prolonged treatment with compound 48/80 on the gastric mucosa and mast cells in the rat.
Ohtsuki H; Takeuchi K; Okabe S
Jpn J Pharmacol; 1985 Jun; 38(2):195-8. PubMed ID: 4032856
[TBL] [Abstract][Full Text] [Related]
17. Gastric mucosal damage by ethanol is mediated by substance P and prevented by ketotifen, a mast cell stabilizer.
Karmeli F; Eliakim R; Okon E; Rachmilewitz D
Gastroenterology; 1991 May; 100(5 Pt 1):1206-16. PubMed ID: 1707383
[TBL] [Abstract][Full Text] [Related]
18. Mast cells in the laryngeal mucosa of the rat. Effect of compound 48/80 and dexamethasone: a quantitative and immunohistochemical study at the light- and electron-microscopic levels.
Lidegran M; Domeij S; Forsgren S; Dahlqvist A
Acta Anat (Basel); 1996; 157(2):135-43. PubMed ID: 9142336
[TBL] [Abstract][Full Text] [Related]
19. Fluctuation of the mucosal hydroxyproline content in compound 48/80-induced gastric lesions in rats.
Arisawa T; Nakazawa S; Segawa K; Tsukamoto Y; Goto H; Hase S; Osada T; Kawabe Y; Kuroiwa M; Tsuchida T
Scand J Gastroenterol Suppl; 1989; 162():27-30. PubMed ID: 2595302
[TBL] [Abstract][Full Text] [Related]
20. Mast cell populations in the chick embryo lung and their response to compound 48/80 and dexamethasone.
Ribatti D; Contino R; Quondamatteo F; Formica V; Tursi A
Anat Embryol (Berl); 1992 Aug; 186(3):241-4. PubMed ID: 1416073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
